Boston Micro Fabrication (BMF)
Leader in micro-precision 3D printing using proprietary Projection Micro Stereolithography (PμSL) technology, enabling ultra-high resolution manufacturing down to 2-micron precision for medical devices, electronics, and advanced research applications.
- CEO / Founder
- John Kawola
- Team Size
- 51-200
- Stage
- Active
- Total Funding
- $67M
- Latest Round
- Series D
- Key Investors
- Series C (2022): Led by Shenzhen Capital Group Co., Ltd. (SCGC). Series D (2023): Led by Guotai Junan Securities. Other investors include National Manufacturing Transformation and Upgrading Fund, Chuanghe Xincai Manufacturing Sector Fund, Guotai Junan Innovation Investment, North Summit Capital.
Technology & Products
Key Products
Projection Micro Stereolithography (PμSL) technology for ultra-high precision and micro-resolution 3D printing.
Technological Advantage
BMF's technology enables the production of complex micro-scale parts that were previously impossible or prohibitively expensive to manufacture. This allows for rapid innovation in product design, especially in miniaturization for the electronics and medical device industries.
Differentiation
Value Proposition
Delivering the precision and tolerances of traditional micro-manufacturing methods (e.g., micro-injection molding) with the speed, design freedom, and cost-efficiency of 3D printing for prototyping and low-volume production.
How They Differentiate
BMF differentiates through its proprietary Projection Micro Stereolithography (PμSL) technology, offering a superior balance of resolution, build speed, and build volume for industrial production. This technology enables ultra-high precision and micro-resolution 3D printing, making it more suitable for industrial production compared to competitors that may focus on even finer resolutions but at slower speeds. Their open material system also provides greater flexibility.
Market & Competition
Target Customers
Companies requiring ultra-high precision micro-parts including medical device manufacturers, electronics producers, biotech firms, and research institutions needing micron-scale 3D printed components.
Industry Verticals
["Medical Devices (implants, surgical tools, microfluidics)", "Electronics (connectors, sensors)", "Aerospace", "Biotech & Life Sciences", "Research & Academia", "Jewelry & Luxury Goods"]
Competitors
Nanoscribe (a BICO company); Microlight3D; UpNano GmbH
Growth & Milestones
Growth Metrics
{"fda_clearance": "510(k) for UltraThineer", "recognition_2024": "Inc. 5000 list", "systems_deployed": "600+", "new_products_2024": "microArch D1025"}
Major Milestones
2025: U.S. Patent for dual-resolution system; FDA 510(k) clearance for UltraThineer material; UltraThineer Lab opening; 2024: Inc. 5000 list; Boston Business Journal MA 5th fastest growing; microArch D1025 launch; 600+ systems deployed globally
Notable Customers
Horizon Microtechnologies (horn antennas), IMcoMET (liquid biopsy microfluidic devices), Aerospace manufacturers, Medical device companies, Electronics manufacturers, Biotechnology firms